Bottom line
How much do TRUH and QAAGZX overlap?
80% of their top holdings overlap by weight. 17 securities appear in both funds' top 25, making up 74.8% of TRUH's assets and 57.7% of QAAGZX's. They are largely the same portfolio — owning both adds little diversification.
QAAGZX holds far more positions (277 vs 60), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings TRUH and QAAGZX have in common
| Holding | % of TRUH | % of QAAGZX | Overlap |
|---|---|---|---|
| Eli Lilly & Co | 16.56% | 14.06% | 14.06% |
| Johnson & Johnson | 10.67% | 6.64% | 6.64% |
| AbbVie Inc | 7.76% | 5.12% | 5.12% |
| UnitedHealth Group Inc | 6.59% | 5.88% | 5.88% |
| Merck & Co Inc | 5.54% | 4.00% | 4.00% |
| Amgen Inc | 3.39% | 1.80% | 1.80% |
| Thermo Fisher Scientific Inc | 3.25% | 2.53% | 2.53% |
| Abbott Laboratories | 2.76% | 1.91% | 1.91% |
| Gilead Sciences Inc | 2.74% | 2.79% | 2.74% |
| Intuitive Surgical Inc | 2.48% | 1.89% | 1.89% |
| CVS Health Corp | 2.31% | 0.93% | 0.93% |
| Vertex Pharmaceuticals Inc | 2.21% | 2.26% | 2.21% |
| Danaher Corp | 2.10% | 1.44% | 1.44% |
| Bristol-Myers Squibb Co | 2.05% | 2.12% | 2.05% |
| Stryker Corp | 1.89% | 1.78% | 1.78% |
| Elevance Health Inc | 1.49% | 1.54% | 1.49% |
| Cardinal Health Inc | 0.97% | 1.04% | 0.97% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in TRUH
- Pfizer Inc — 2.40%
- Medtronic PLC — 1.76%
- McKesson Corp — 1.54%
- Cigna Group/The — 1.26%
- Regeneron Pharmaceuticals Inc — 1.12%
- Boston Scientific Corp — 1.11%
- HCA Healthcare Inc — 1.08%
- Cencora Inc — 0.95%
Only in QAAGZX
- Natera Inc — 1.44%
- Guardant Health Inc — 1.22%
- Royalty Pharma Plc- Cl A — 0.97%
- Tenet Healthcare Corp — 0.94%
- Kymera Therapeutics Inc — 0.89%
- T. Rowe Price Government Reserve Fund — 0.87%
- Protagonist Therapeutics Inc — 0.85%
- Moderna Therapeutics Inc — 0.83%
Asset mix
| Asset type | TRUH | QAAGZX |
|---|---|---|
| Stocks | 99.9% | 96.9% |
| Preferred stock | — | 2.2% |
| Cash & short-term funds | — | 0.9% |
| Bonds | — | 0.1% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)
Country mix
| Country | TRUH | QAAGZX |
|---|---|---|
| US | 97.8% | 92.3% |
| IE | 2.1% | 0.8% |
| GB | — | 1.8% |
| NL | — | 1.0% |
| BM | — | 0.7% |
| DK | — | 0.7% |
| CA | — | 0.6% |
| CH | — | 0.5% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)
Check another pair
FAQ
How much do TRUH and QAAGZX overlap?
What stocks do TRUH and QAAGZX have in common?
Should I own both TRUH and QAAGZX?
Which holds more stocks, TRUH or QAAGZX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.